The University of Alberta’s Li Ka Shing Institute of Virology has received a $1.5M investment from GSK toward the GSK Chair in Virology. The investment will increase the value of the endowed chair to almost $6M and will be used to support the recruitment of high-quality scientists to future LKSloV leadership roles and help create jobs in the industry. “Industry funding allows us to take substances that are discovered at universities to a product that can be sold in a pharmacy for patients to access,” said GSK Chair in Virology Dr Lorne Tyrell.
Newswire
